• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Applying Desirability of Outcome Ranking End Points.

作者信息

Dunne Michael W, Aronin Steven I, Das Anita F, Gupta Jayanti, Akinapelli Karthik, Zelasky Michael T, Puttagunta Sailaja, Boucher Helen W

机构信息

Iterum Therapeutics, Old Saybrook, Connecticut, USA.

Das Statistical Consulting, Guerneville, California, USA.

出版信息

Clin Infect Dis. 2023 Jul 5;77(1):159-161. doi: 10.1093/cid/ciad166.

DOI:10.1093/cid/ciad166
PMID:36974506
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10320050/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f68e/10320050/09f6f5b4e9ea/ciad166f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f68e/10320050/09f6f5b4e9ea/ciad166f1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/f68e/10320050/09f6f5b4e9ea/ciad166f1.jpg

相似文献

1
Applying Desirability of Outcome Ranking End Points.应用结果期望等级终点。
Clin Infect Dis. 2023 Jul 5;77(1):159-161. doi: 10.1093/cid/ciad166.
2
Methodologies for pragmatic and efficient assessment of benefits and harms: Application to the SOCRATES trial.实用且高效的获益与风险评估方法学：SOCRATES 试验的应用。
Clin Trials. 2020 Dec;17(6):617-626. doi: 10.1177/1740774520941441. Epub 2020 Jul 15.
3
Improving Traditional Registrational Trial End Points: Development and Application of a Desirability of Outcome Ranking End Point for Complicated Urinary Tract Infection Clinical Trials.改进传统注册临床试验终点：复杂尿路感染临床试验结局排序终点的制定与应用。
Clin Infect Dis. 2023 Feb 8;76(3):e1157-e1165. doi: 10.1093/cid/ciac692.
4
Applying Desirability of Outcome Ranking End Point to Randomized Trial of Sulopenem for the Treatment of Complicated Urinary Tract Infections.将结局排序终点的合意性应用于舒洛培南治疗复杂性尿路感染的随机试验。
Clin Infect Dis. 2023 Jun 16;76(12):2213-2215. doi: 10.1093/cid/ciad149.
5
Desirability-based methods of multiobjective optimization and ranking for global QSAR studies. Filtering safe and potent drug candidates from combinatorial libraries.基于合意性的多目标优化方法及全局定量构效关系研究中的排序。从组合文库中筛选安全有效的候选药物。
J Comb Chem. 2008 Nov-Dec;10(6):897-913. doi: 10.1021/cc800115y. Epub 2008 Oct 15.
6
A desirability of outcome ranking (DOOR) for periprosthetic joint infection - a Delphi analysis.人工关节感染的预后排名期望度（DOOR）——德尔菲分析
J Bone Jt Infect. 2022 Nov 10;7(6):221-229. doi: 10.5194/jbji-7-221-2022. eCollection 2022.
7
Desirability of Outcome Ranking for the Management of Antimicrobial Therapy (DOOR MAT): A Framework for Assessing Antibiotic Selection Strategies in the Presence of Drug Resistance.治疗抗菌药物管理中结果排序的可取性 (DOOR MAT)：在存在药物耐药性的情况下评估抗生素选择策略的框架。
Clin Infect Dis. 2021 Jul 15;73(2):344-350. doi: 10.1093/cid/ciaa1769.
8
Desirability of outcome ranking and quality life measurement for antimicrobial research in organ transplantation.器官移植中抗菌药物研究的结果排序和生活质量测量的可取性。
Transpl Infect Dis. 2022 Oct;24(5):e13888. doi: 10.1111/tid.13888.
9
The adaptation of the desirability of outcome ranking for interventional clinical trials in epilepsy: A novel consumer-led outcome measure.癫痫介入临床试验结局排序适宜性的调整：一种新的以患者为中心的结局指标。
Epilepsia Open. 2023 Dec;8(4):1608-1615. doi: 10.1002/epi4.12839. Epub 2023 Oct 11.
10
Data mining by total ranking methods: a case study on optimisation of the "pulp and bleaching" process in the paper industry.基于全排序方法的数据挖掘：以造纸工业中“制浆与漂白”工艺优化为例的研究
Ann Chim. 2006 Jan-Feb;96(1-2):13-27. doi: 10.1002/adic.200690004.

本文引用的文献

1
Sulopenem or Ciprofloxacin for the Treatment of Uncomplicated Urinary Tract Infections in Women: A Phase 3, Randomized Trial.舒巴坦匹酯或环丙沙星治疗女性单纯性尿路感染的随机对照 3 期临床试验
Clin Infect Dis. 2023 Jan 6;76(1):66-77. doi: 10.1093/cid/ciac738.
2
Sulopenem for the Treatment of Complicated Urinary Tract Infections Including Pyelonephritis: A Phase 3, Randomized Trial.硫酸头孢噻肟治疗包括肾盂肾炎在内的复杂性尿路感染的 3 期随机试验。
Clin Infect Dis. 2023 Jan 6;76(1):78-88. doi: 10.1093/cid/ciac704.
3
Improving Traditional Registrational Trial End Points: Development and Application of a Desirability of Outcome Ranking End Point for Complicated Urinary Tract Infection Clinical Trials.
改进传统注册临床试验终点：复杂尿路感染临床试验结局排序终点的制定与应用。
Clin Infect Dis. 2023 Feb 8;76(3):e1157-e1165. doi: 10.1093/cid/ciac692.
4
Clinical Practice Guideline for the Management of Asymptomatic Bacteriuria: 2019 Update by the Infectious Diseases Society of America.美国传染病学会 2019 年无症状菌尿管理临床实践指南更新版。
Clin Infect Dis. 2019 May 2;68(10):1611-1615. doi: 10.1093/cid/ciz021.
5
Distribution-free confidence intervals for a parameter of Wilcoxon-Mann-Whitney type for ordered categories and progressive censoring.有序类别和渐进删失情形下Wilcoxon-Mann-Whitney型参数的无分布置信区间
Biometrics. 1989 Jun;45(2):509-21.